<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Vaping and e-cigarettes</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Vaping and e-cigarettes</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Vaping and e-cigarettes</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy A Rigotti, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Krishna P Reddy, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark D Aronson, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Umur Hatipoglu, MD, MBA</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sara Swenson, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 04, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H28394366"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Electronic cigarettes (e-cigarettes) are battery-operated devices that heat a liquid usually containing nicotine, producing an aerosol that the user inhales (<a class="graphic graphic_figure graphicRef98585" href="/d/graphic/98585.html" rel="external">figure 1</a>) [<a href="#rid1">1</a>]. E-cigarettes entered the market in 2003 in China and entered the United States and European markets in 2006 [<a href="#rid2">2</a>]. In many areas, e-cigarettes entered the market as consumer products without government regulation. Initially produced by small companies, tobacco companies have bought some of these companies and are developing these products [<a href="#rid3">3</a>]. They are available both online and in traditional retail outlets.</p><p>There is uncertainty about the long-term health effects of e-cigarettes and whether they will help individual tobacco users to stop smoking [<a href="#rid4">4-7</a>]. There are also public health concerns, including concerns about the effect of e-cigarettes on smoking prevalence and their potential use by children as a gateway to nicotine dependence and subsequent combustible tobacco product use [<a href="#rid8">8</a>].</p><p>This topic will provide an overview of e-cigarettes, including information about devices, use, components, adverse health effects, use in smoking cessation, impact on public health, as well as suggestions for patient counseling. An overview of smoking cessation and pharmacotherapies and behavioral therapies for smoking cessation are discussed in detail in the following topic reviews:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/16634.html" rel="external">"Overview of smoking cessation management in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/16635.html" rel="external">"Pharmacotherapy for smoking cessation in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6920.html" rel="external">"Behavioral approaches to smoking cessation"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14583.html" rel="external">"Prevention of smoking and vaping initiation in children and adolescents", section on 'Vaping nicotine'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/115306.html" rel="external">"Tobacco and nicotine use in pregnancy: Cessation strategies and treatment options"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4803.html" rel="external">"Cigarette and tobacco products in pregnancy: Impact on pregnancy and the neonate"</a>.)</p><p></p><p class="headingAnchor" id="H1032355223"><span class="h1">ELECTRONIC NICOTINE DELIVERY SYSTEMS</span></p><p class="headingAnchor" id="H3678976730"><span class="h2">E-cigarette devices</span><span class="headingEndMark"> — </span>E-cigarettes are a type of electronic nicotine delivery system (ENDS) consisting of a cartridge containing a liquid, an atomizer (vaporization chamber with a heating element), and a battery (<a class="graphic graphic_figure graphicRef98585" href="/d/graphic/98585.html" rel="external">figure 1</a>) [<a href="#rid9">9</a>].</p><p>The user activates the atomizer either by inhaling or by pressing a button, depending on the device characteristics. The atomizer then heats and aerosolizes the liquid in the cartridge, creating an aerosol that emulates but is not tobacco smoke. This process simulates the experience of smoking a conventional cigarette, but no combustion occurs. The term "vaping" is used to distinguish the process from smoking a conventional cigarette. The term “dripping” is used to describe a technique in which a couple of drops of the liquid in the e-cigarette cartridge are dripped directly onto the atomizer’s heating element to create a cloud of aerosol that can be inhaled [<a href="#rid10">10</a>].</p><p>E-cigarettes originally were designed to resemble conventional cigarettes, but e-cigarette technology is rapidly evolving. Newer versions resemble cigarettes less and feature rechargeable batteries as well as heating elements and refillable cartridges that can deliver higher concentrations of nicotine (<a class="graphic graphic_figure graphicRef126552" href="/d/graphic/126552.html" rel="external">figure 2</a>) [<a href="#rid1">1</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>First-generation products – First-generation e-cigarettes mimic the shape and size of conventional cigarettes and may be referred to as "cigalikes." They are neither rechargeable nor refillable and are discarded after they stop producing aerosol.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Second-generation products – Second-generation e-cigarettes are larger than conventional cigarettes and are either pen-style (medium size) or tank-style (large size). Both feature rechargeable batteries that may have a switch or electronic circuits that allow users to regulate the frequency and length of puffs or the power delivery to the atomizer. The cartridges in second-generation e-cigarettes are refillable and allow the user to adjust the contents of the e-cigarette liquid.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Third-generation products – Third-generation e-cigarettes are similar to second-generation devices but allow for more custom modifications [<a href="#rid1">1</a>]. They are known as "personalized vaporizers." There are a range of options for cartridges and atomizers; some devices allow the user to adjust the resistance of the atomizer, which produces higher heating temperatures. Users can also pair different atomizers with high-capacity batteries to increase aerosol production and battery life.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fourth-generation products – “Pod-mod devices” are a type of e-cigarette that has been increasing in popularity among adolescents [<a href="#rid11">11</a>]. These rechargeable devices have replaceable cartridges that contain nicotine and flavorings. A popular brand is JUUL, a device that resembles a USB flash drive. JUUL’s small size and discreet appearance make it easy for the device use to go unnoticed in school settings. JUUL devices can deliver higher concentrations of nicotine without throat irritation because they contain nicotine in a form that is less irritating to the throat.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Novel devices – Similar to first-generation products, these small, often brightly colored devices are non-rechargeable and disposable, and they are available in many flavors (eg, fruit, candy, mint) [<a href="#rid12">12-14</a>].</p><p></p><p class="headingAnchor" id="H1032355305"><span class="h2">E-cigarette liquid components</span><span class="headingEndMark"> — </span>Unlike conventional cigarettes, which burn tobacco and generate smoke, e-cigarettes have a cartridge containing a liquid (sometimes referred to as "vape juice," "e-juice," or "e-liquid"). The liquid is heated to produce an aerosol the user inhales [<a href="#rid1">1</a>]. Nicotine e-cigarettes contain nicotine and other constituents, some with carcinogenic potential [<a href="#rid1">1,15-18</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nicotine</strong> – The nicotine content of e-cigarettes and liquids varies and usually ranges from none (nicotine-free) up to 36 mg/mL, though it can be higher [<a href="#rid1">1,19</a>]. Common nicotine concentrations of e-cigarette liquids are 6 mg/mL, 12 mg/mL, 18 mg/mL, or 24 mg/mL. Some e-cigarette liquids contain nicotine salts, in which nicotine is combined with an acid [<a href="#rid20">20</a>]. Use of nicotine salts may have a different sensation in a user’s throat [<a href="#rid20">20</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Propylene glycol/glycerol</strong> – Propylene glycol or glycerol are humectants that are the main components of most e-cigarette liquids; some products may use ethylene glycol [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Flavorings</strong> – E-cigarettes may have added characterizing flavors. More than 7000 flavors are available, including candy, fruit, soda, and alcohol flavors [<a href="#rid22">22</a>]. Flavorings may increase the attractiveness of e-cigarettes to youths, especially those who do not already smoke [<a href="#rid23">23</a>].</p><p></p><p>Metals such as tin, lead, nickel, chromium, manganese, and arsenic have been found in some e-cigarette liquids and aerosol [<a href="#rid24">24,25</a>]. Other compounds detected include tobacco-specific nitrosamines, carbonyl compounds, metals, volatile organic compounds, and phenolic compounds [<a href="#rid1">1,18,26,27</a>]. Vaping devices can be used to aerosolize tetrahydrocannabinol (THC) or cannabinoid (CBD) oils.</p><p class="headingAnchor" id="H673852336"><span class="h2">Heat-not-burn tobacco products</span><span class="headingEndMark"> — </span>Another type of heating device is used in heat-not-burn (HNB) tobacco products. The device heats tobacco to a much lower temperature than that of a conventional tobacco cigarette. In July 2020, the US Food and Drug Administration (FDA) approved the manufacturer’s request to market these devices with the claim that they reduce exposure to tobacco toxins [<a href="#rid28">28</a>]. HNB products are described separately. (See  <a class="medical medical_review" href="/d/html/6916.html" rel="external">"Patterns of tobacco use", section on 'Heat-not-burn tobacco products'</a>.)</p><p class="headingAnchor" id="H3632574907"><span class="h1">PREVALENCE AND PATTERNS OF USE</span></p><p class="headingAnchor" id="H822632712"><span class="h2">Prevalence</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adults</strong> – The National Health Interview Survey (NHIS), which provides nationally representative estimates of e-cigarette use among adults in the United States, showed an overall increase in the prevalence of current e-cigarette use among adults between 2014 to 2019 (from 3.7 to 4.9 percent), with a transient decline in 2020 to 3.7 percent [<a href="#rid29">29-32</a>] and rebound in 2021 to 4.5 percent [<a href="#rid33">33</a>]. The prevalence of current e-cigarette use is highest among young adults (ages 18 to 24 years), having increased from 7.6 to 11.0 percent between 2018 and 2021. The prevalence of e-cigarette use declines with increasing age [<a href="#rid33">33</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Youth</strong> – Between 2013 and 2019, national surveys of middle and high school students in the United States revealed an upward trend in tobacco use in the past 30 days (the measure used to define current use among adolescents), with the greatest increase being in e-cigarette use (<a class="graphic graphic_figure graphicRef126349" href="/d/graphic/126349.html" rel="external">figure 3</a> and <a class="graphic graphic_figure graphicRef126348" href="/d/graphic/126348.html" rel="external">figure 4</a>) [<a href="#rid23">23,34-36</a>].</p><p></p><p class="bulletIndent1">However, the National Youth Tobacco Survey (NYTS) reported a subsequent large decline in e-cigarette use among United States adolescents [<a href="#rid14">14,36,37</a>]. From 2019 to 2021, e-cigarette use declined from 28 to 11.3 percent among high school students and from 11 to 2.8 percent among middle school students, a timing that coincided with the coronavirus disease 2019 (COVID-19) pandemic. The 2022 NYTS reported a partial rebound in e-cigarette use, with 14.1 percent of high school students and 3.3 percent of middle school students reporting current use [<a href="#rid38">38</a>]. Although some of the observed prevalence trends in e-cigarette use during 2021 and 2022 may be attributable to changes in survey methodology, the size of the decline over consecutive years likely reflects some true decrease in prevalence.</p><p></p><p class="headingAnchor" id="H1437325722"><span class="h2">Patterns of use</span><span class="headingEndMark"> — </span>E-cigarette use (ever or current use) is more common among younger age groups, males, and non-Hispanic White adults [<a href="#rid32">32,39-41</a>].</p><p>Youth e-cigarette users generally do not use the product daily [<a href="#rid42">42-44</a>]. As an example, in the 2022 NYTS, daily e-cigarette use was reported by only 4.2 percent of high school students and 1.0 percent of middle school students, representing less than one-third of high school and middle school students reporting any current use [<a href="#rid14">14</a>].</p><p>Most current adult users of e-cigarettes have smoked conventional cigarettes [<a href="#rid39">39,41</a>]. Although the prevalence of e-cigarette use among those who currently smoke remained stable from 2014 to 2018, it increased among adults who previously smoked. As an example, in a NHIS survey of young adults who previously smoked, current e-cigarette use increased from 10.4 to 36.5 percent from 2014 to 2018 [<a href="#rid30">30</a>]. Similarly, current e-cigarette use among all adults who previously smoked increased from 4.2 to 5.5 percent [<a href="#rid29">29</a>] from 2017 to 2018.</p><p>Adults who recently quit smoking are more likely to use e-cigarettes regularly than those who formerly smoked [<a href="#rid45">45</a>].</p><p>In contrast, e-cigarette use is uncommon among adults who have never smoked cigarettes. As an example, among adults who had never smoked cigarettes, only 6.5 percent had ever used e-cigarettes and 1.1 percent currently used them [<a href="#rid39">39</a>]. Similarly, in the United Kingdom in 2015, an estimated 1.7 percent of those who had never smoked were current e-cigarette users [<a href="#rid46">46</a>]. However, among United States young adults, current e-cigarette use in those who never smoked increased from 2014 to 2018 (from 1.5 to 4.6 percent) [<a href="#rid30">30</a>].</p><p>Studies indicate that most e-cigarette users perceive these products to be a tool to quit conventional cigarettes or to reduce their risk of tobacco-related disease [<a href="#rid41">41,47,48</a>]. For example, in a survey of 2501 United States adults who smoke, there was a greater interest in using e-cigarettes for the purpose of smoking cessation or reduction than for novelty or to cope with smoking restrictions [<a href="#rid49">49</a>].</p><p class="headingAnchor" id="H1102655289"><span class="h1">ADVERSE HEALTH EFFECTS</span><span class="headingEndMark"> — </span>Potential adverse effects of e-cigarettes are related to exposure to nicotine as well as to other aerosol components produced by the devices and risks of the actual device.</p><p class="headingAnchor" id="H1102655710"><span class="h2">Nicotine exposure</span><span class="headingEndMark"> — </span>Nicotine exposure from e-cigarette use, as with cigarette smoking, increases heart rate and produces measurable levels of blood cotinine, a nicotine metabolite [<a href="#rid50">50</a>]. (See  <a class="medical medical_review" href="/d/html/1517.html" rel="external">"Cardiovascular effects of nicotine", section on 'Smoking and cardiovascular risk'</a>.)</p><p>The amount of nicotine delivered and the level of nicotine in the blood varies depending on nicotine concentration in the e-cigarette liquid, other components in the e-cigarette liquid, user experience, puffing intensity, device characteristics, and vaping technique [<a href="#rid51">51</a>]. Experienced e-cigarette users tend to take longer puffs and use the device more intensively compared with novice users [<a href="#rid52">52</a>]. As a consequence, they have higher blood nicotine levels that more closely resemble the levels achieved by smoking conventional cigarettes [<a href="#rid1">1,50,53-55</a>]. In less-experienced users, however, the nicotine delivered by e-cigarettes is consistently lower than nicotine delivered by conventional cigarettes [<a href="#rid56">56,57</a>].</p><p>Data on the health consequences of chronic nicotine exposure alone in the absence of cigarette smoking are available from studies of chronic users of nicotine replacement products. These data do not suggest that chronic nicotine exposure increases long-term cardiopulmonary or cancer risk. (See  <a class="medical medical_review" href="/d/html/1517.html" rel="external">"Cardiovascular effects of nicotine", section on 'Safety of nicotine replacement therapy'</a>.)</p><p class="headingAnchor" id="H3440161818"><span class="h2">Aerosol (also known as vapor) exposure</span><span class="headingEndMark"> — </span>Commercially manufactured e-cigarettes do not expose the user to many of the constituents of cigarette smoke (eg, tars, oxidant gases, and carbon monoxide) that are responsible for many of the tobacco-attributable diseases [<a href="#rid58">58</a>]. However, most manufactured e-cigarettes do contain a number of potentially toxic chemical substances [<a href="#rid1">1</a>]. Furthermore, people may refill empty e-cigarette cartridges with various substances and carriers that may increase risk of harm when heated for inhalation.</p><p>In 2019, the Centers for Disease Control and Prevention (CDC) reported over two thousand suspected cases of severe lung illnesses (e-cigarette, or vaping, product use associated lung injury [EVALI]) linked to the use of e-cigarette devices to aerosolize substances for inhalation [<a href="#rid59">59-64</a>]. In the majority of cases, tetrahydrocannabinol (THC) had been inhaled within three months of symptom onset; many patients had also inhaled nicotine, and some patients had inhaled only nicotine [<a href="#rid62">62</a>]. Refilled e-cigarette cartridges obtained via informal or illicit sources and contaminated with vitamin E acetate appear to be most strongly associated with EVALI cases, and vitamin E acetate has been detected in bronchoalveolar lavage fluid samples obtained from affected patients [<a href="#rid60">60,61,65</a>]. EVALI is discussed in greater detail elsewhere. (See  <a class="medical medical_review" href="/d/html/122671.html" rel="external">"E-cigarette or vaping product use-associated lung injury (EVALI)"</a>.)</p><p>E-cigarette use has also been associated with the development of acute eosinophilic pneumonia. (See  <a class="medical medical_review" href="/d/html/4374.html" rel="external">"Idiopathic acute eosinophilic pneumonia", section on 'Etiology'</a>.)</p><p>Prior to the emergence of EVALI, most experts believed that inhaling e-cigarette aerosol was less likely to be harmful (acutely or chronically) than inhaling cigarette smoke [<a href="#rid1">1,2,66</a>]. The consequences of chronic e-cigarette aerosol inhalation are largely unknown, and levels of toxic and carcinogenic compounds may vary depending on the e-cigarette liquid components and device used [<a href="#rid67">67</a>]. Little is known about the overall safety or the carcinogenic effects of propylene glycol or glycerol when heated and aerosolized. At high temperatures, propylene glycol decomposes and may form propylene oxide, a probable human carcinogen [<a href="#rid68">68</a>]. Glycerol produces the toxin acrolein, though the levels produced are lower than conventional cigarettes [<a href="#rid15">15</a>]. Both propylene glycol and glycerol decompose to form the carcinogens formaldehyde and acetaldehyde, with levels depending on the voltage of the battery used in the e-cigarette [<a href="#rid67">67,69</a>].</p><p>Other carcinogenic compounds have been found in e-cigarettes, but in trace amounts that are much lower than levels found in conventional cigarettes. These include tobacco-specific nitrosamines (TSNAs), carbonyl compounds, metals, volatile organic compounds (VOCs), and phenolic compounds [<a href="#rid1">1,18,26,27</a>]. A small observational study found that users of e-cigarettes for at least six months (who did not smoke conventional cigarettes) had substantially lower urinary and salivary concentrations of TSNAs and VOCs than did those who smoked conventional cigarettes [<a href="#rid54">54</a>]. It is not known whether the particles in e-cigarette aerosol have any toxicity. (See  <a class="medical medical_review" href="/d/html/6919.html" rel="external">"Secondhand smoke exposure: Effects in adults"</a> and  <a class="medical medical_review" href="/d/html/6375.html" rel="external">"Secondhand smoke exposure: Effects in children", section on 'Is exposure to e-cigarette vapor harmful?'</a>.)</p><p>The long-term cardiovascular risks of e-cigarette use are unknown but are thought to be substantially lower than the risks of smoking [<a href="#rid70">70</a>]. Aerosol constituents that may influence this risk include nicotine, oxidizing chemicals, particulate matter, and acrolein [<a href="#rid71">71</a>]. A small observational study found that e-cigarette use for at least one year was associated with factors that have been correlated with increased cardiovascular risk: increased oxidative stress and a shift toward sympathetic predominance in cardiac autonomic balance [<a href="#rid72">72</a>]. By contrast, another small study found that, compared with a sham control or non-nicotine e-cigarette, acute exposure to an e-cigarette containing nicotine was not associated with increased oxidative stress but was associated with increased cardiac sympathetic nerve activity [<a href="#rid73">73</a>]. A randomized control trial found that those who switched from conventional to e-cigarettes had improvement in endothelial function and vascular stiffness within one month [<a href="#rid74">74</a>].</p><p>The use of nicotine containing e-cigarettes may cause a mild, short-term increase in blood pressure [<a href="#rid73">73,75</a>], although the long-term effects on blood pressure are unclear. (See  <a class="medical medical_review" href="/d/html/3866.html" rel="external">"Smoking and hypertension", section on 'E-cigarettes and blood pressure'</a>.)</p><p>Although limited evidence on the effects of e-cigarette aerosol suggests that changes in airway respiratory function are much smaller than those associated with conventional cigarettes, there may be an association with cough and asthma symptoms, particularly among adolescents [<a href="#rid1">1,6</a>]. In one survey of over 45,000 students (mean age 14.6 years) in Hong Kong, e-cigarette use was associated with respiratory symptoms (cough or phlegm), regardless of cigarette smoking status [<a href="#rid76">76</a>]. Similarly, in a survey of 11<sup>th</sup>- and 12<sup>th</sup>-grade students in California, there was an association between self-reported chronic bronchitic symptoms (chronic cough, phlegm, or bronchitis within the past year) and current or past e-cigarette use that remained after adjustment for cigarette smoking or secondhand smoke exposure; the risk increased with frequency of current e-cigarette use [<a href="#rid77">77</a>]. Among adults, there is some evidence of an association between e-cigarette use and respiratory symptoms, although the risk appears to be lower than that with cigarette smoking [<a href="#rid78">78,79</a>].</p><p>The effect of inhaling flavorings on respiratory function is also uncertain [<a href="#rid80">80</a>]. Some studies have found a link between cytotoxicity and certain flavorings used in e-cigarette liquids, especially sweet and cinnamon flavors [<a href="#rid81">81-85</a>]. Specifically, diacetyl, a chemical associated with respiratory diseases, has been found in sweet-flavored e-cigarettes [<a href="#rid86">86</a>]. Cherry-flavored e-cigarettes have been found to contain benzaldehyde, a compound that has been associated with respiratory irritation [<a href="#rid87">87</a>].</p><p>No observational data examining the long-term risk of cancer from e-cigarettes exist; however, the risk of cancer is likely to be much lower in adults who use e-cigarettes than in those who smoke conventional cigarettes [<a href="#rid1">1,70,88</a>].</p><p class="headingAnchor" id="H1445352451"><span class="h2">Risks of devices</span><span class="headingEndMark"> — </span>E-cigarette devices have been reported to cause burns, explosive injuries, and chemical injuries [<a href="#rid70">70,89-92</a>].</p><p>Several reviews have identified emergency department visits for burns from electronic nicotine delivery systems (ENDS) due to device malfunction either while stored (eg, in a pocket) or during use, resulting in burns to the thigh, groin, face, and/or hand [<a href="#rid92">92,93</a>].</p><p>In addition, exposure to e-cigarette liquid via oral or parenteral ingestion, or through skin contact, can also cause harm, particularly to young children. Such exposure may commonly cause nausea, vomiting, lethargy, and tachycardia and may even result in seizures, anoxic brain injury, lactic acidosis, and death. (See  <a class="medical medical_review" href="/d/html/130609.html" rel="external">"Nicotine poisoning (e-cigarettes, tobacco products, plants, and pesticides)"</a>.)</p><p class="headingAnchor" id="H881599345"><span class="h1">CONCERNS RELATED TO YOUTH AND NONSMOKERS</span><span class="headingEndMark"> — </span>For adolescents and others who are not established cigarette smokers, the primary focus is on the potential risks of e-cigarette use. Non-smokers are not using e-cigarettes to help them stop using conventional cigarettes, so there is no mitigating harm-reduction. Concerns about the risks of e-cigarettes are accentuated by the rapidly increasing prevalence of e-cigarette use among youth in the United States (<a class="graphic graphic_figure graphicRef126349" href="/d/graphic/126349.html" rel="external">figure 3</a> and <a class="graphic graphic_figure graphicRef126348" href="/d/graphic/126348.html" rel="external">figure 4</a>), with many adolescents reporting very frequent use, including during the school day. (See <a class="local">'Prevalence'</a> above.)</p><p>Specific concerns about e-cigarette use by youth include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nicotine dependence</strong> – Use of e-cigarettes raises the risk of establishing nicotine dependence in novice users, which could ultimately lead to combustible tobacco use. This potential gateway effect is suggested by observations that e-cigarette use often precedes conventional cigarette use [<a href="#rid94">94-99</a>]. As examples:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A systematic review and meta-analysis of longitudinal studies among 17,389 adolescents and young adults aged 14 to 30 years showed that, compared with e-cigarette never users, ever users had a higher probability of initiating cigarette smoking (31 versus 8 percent, pooled adjusted odds ratio [OR] 3.50 [95% CI, 2.38-5.16]) [<a href="#rid97">97,100</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a prospective study of ninth-grade students, an association was seen between use of e-cigarettes and other forms of tobacco and use of conventional cigarettes. After adjusting for other risk factors for smoking, baseline e-cigarette use was associated with a greater likelihood of using any combustible tobacco product (OR 2.7, 95% CI 2.0-3.7), including conventional cigarettes (OR 2.7, 95% CI 1.7-4.0), cigars (OR 4.9, 95% CI 3.4-7.0), and hookahs (OR 3.3, 95% CI 2.3-4.6) [<a href="#rid94">94</a>].</p><p></p><p class="bulletIndent1">Some of these findings may be related to the association between the predisposition of an adolescent or young adult to smoke conventional cigarettes and their predisposition to smoke e-cigarettes. However, analysis of psychosocial risk factors suggests that many youth who use e-cigarettes are unlikely to have initiated tobacco smoking with cigarettes [<a href="#rid101">101</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adverse effects</strong> – E-cigarette use raises the risk of adverse effects (eg, respiratory symptoms), some of which have been reported particularly among youth [<a href="#rid76">76,77,102</a>]. (See <a class="local">'Aerosol (also known as vapor) exposure'</a> above and  <a class="medical medical_review" href="/d/html/122671.html" rel="external">"E-cigarette or vaping product use-associated lung injury (EVALI)"</a>.)</p><p></p><p class="bulletIndent1">In addition, one internet survey of adolescents and young adults found that dual use of cigarettes and e-cigarettes may be associated with an increased risk of self-reported infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes COVID-19 [<a href="#rid103">103</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Normalizing smoking behavior</strong> – E-cigarette use may normalize smoking behavior, which might contribute to conventional cigarette use. (See <a class="local">'Renormalization of smoking behavior'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The long-term effects of nicotine exposure through e-cigarette use only, including the effects of e-cigarette use during pregnancy, are not known. (See  <a class="medical medical_review" href="/d/html/4803.html" rel="external">"Cigarette and tobacco products in pregnancy: Impact on pregnancy and the neonate"</a>.)</p><p></p><p>Given the concerns that e-cigarette use may be a gateway to nicotine dependence among adolescents, many public health authorities have recommended restricting e-cigarette marketing and advertising to youth and banning flavorings, similar to strategies used to reduce tobacco use by youth [<a href="#rid104">104-107</a>]. (See <a class="local">'Regulatory status'</a> below and  <a class="medical medical_review" href="/d/html/14583.html" rel="external">"Prevention of smoking and vaping initiation in children and adolescents", section on 'Advertising and media influence'</a>.)</p><p>There is ample evidence that e-cigarettes have been marketed using many of the strategies previously used by tobacco companies to market conventional cigarettes to youth [<a href="#rid108">108</a>]. For example, e-cigarettes have been commonly marketed with flavorings, which appeal to youths and are banned in conventional cigarettes for this reason [<a href="#rid22">22,109</a>]. Exposure to e-cigarette marketing has been associated with e-cigarette use among youth and young adults [<a href="#rid110">110,111</a>].</p><p>These issues are discussed in more detail separately. (See  <a class="medical medical_review" href="/d/html/14583.html" rel="external">"Prevention of smoking and vaping initiation in children and adolescents", section on 'Vaping nicotine'</a>.)</p><p class="headingAnchor" id="H28394414"><span class="h1">ROLE IN SMOKING CESSATION</span><span class="headingEndMark"> — </span>The available clinical trial evidence suggests that e-cigarettes may be effective as smoking cessation aids, but more trials are needed to fully evaluate the safety and efficacy of e-cigarettes for smoking cessation [<a href="#rid1">1,7,112,113</a>]. E-cigarettes may be more attractive to users than other medications for smoking cessation because they look and taste more like conventional cigarettes and permit the user to continue the hand-to-mouth ritual of smoking [<a href="#rid114">114</a>]. In small studies, users of e-cigarettes reported reduced conventional cigarette cravings and nicotine withdrawal symptoms [<a href="#rid50">50,53</a>]. However, there is the theoretical concern that e-cigarettes could deter people from using smoking cessation medications with a known record of safety and efficacy [<a href="#rid58">58</a>]. The American Thoracic Society recommends using proven pharmacotherapy (ie, <a class="drug drug_general" data-topicid="10339" href="/d/drug information/10339.html" rel="external">varenicline</a>) rather than e-cigarettes for smoking cessation, and the US Preventive Services Task Force concludes that the evidence is insufficient to fully evaluate the benefits and harms of e-cigarettes for smoking cessation [<a href="#rid112">112,115</a>]. This is reviewed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/16635.html" rel="external">"Pharmacotherapy for smoking cessation in adults"</a>.)</p><p>Some people who have stopped using conventional cigarettes (and therefore are considered to have quit) may or may not continue to use e-cigarettes [<a href="#rid116">116</a>]. However, discontinuing both conventional cigarettes and e-cigarettes is advisable in order to avoid whatever longer-term risk may be associated with e-cigarettes alone. The nature and magnitude of these risks are uncertain at this time.</p><p class="headingAnchor" id="H1102655949"><span class="h2">Efficacy</span><span class="headingEndMark"> — </span>There is increasing evidence from randomized clinical trials that e-cigarettes are effective for smoking cessation, although the long-term effectiveness and safety of e-cigarettes compared with available pharmacotherapies is uncertain based upon limited high-quality data [<a href="#rid1">1,7,70,113</a>]. In addition, most trials used earlier e-cigarette products, which may limit the generalizability of trial results; newer e-cigarette devices allow for a higher nicotine dose delivery, and these products may be more effective for smoking cessation than earlier devices [<a href="#rid117">117</a>]. Further randomized trials, specifically using later e-cigarette devices, are needed.</p><p>In published studies:</p><p class="bulletIndent1"><span class="glyph">●</span>In a randomized trial including almost 900 people who smoked combustible tobacco cigarettes in the United Kingdom, e-cigarettes were more effective in smoking cessation than nicotine replacement therapy (NRT) at one year [<a href="#rid116">116</a>]. Participants were provided either an e-cigarette starter pack or nicotine replacement products of their choice for three months; all users were provided at least four weekly behavioral support sessions. Biochemically proven cigarette abstinence rates at one year were 18.0 percent in the e-cigarette user group and 9.9 percent in the NRT group (relative risk [RR] 1.83; 95% CI 1.20-2.58). Among those who were abstinent from cigarettes at one year, 80 percent of those in the e-cigarette group were still using e-cigarettes, compared with 9 percent of those in the NRT group who continued to use NRT. At one year, those in the e-cigarette group had greater declines in the incidence of cough and phlegm production compared with those in the NRT group. The safety of sustained e-cigarette use after quitting conventional cigarette smoking represents harm reduction, although whether long-term e-cigarette use among those who formerly smoked conventional cigarettes has any negative long-term health consequences is not yet known.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a randomized trial, approximately 375 Canadian adults who smoked conventional cigarettes were assigned to receive nicotine e-cigarettes, non-nicotine e-cigarettes, or no e-cigarettes for 12 weeks; all groups received counseling [<a href="#rid7">7</a>]. At 12 weeks, self-reported smoking abstinence (point prevalence) was greater among those receiving nicotine e-cigarettes plus counseling compared with counseling alone (22 versus 9 percent); the difference became nonsignificant by 24 weeks. Interpretation of the trial results, however, is limited by methodologic issues, including early termination and underpowering to detect study group differences.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another randomized trial including over 650 adults who smoked conventional cigarettes in New Zealand, participants were randomly assigned to nicotine-containing (16 mg) e-cigarettes, nicotine-free e-cigarettes, or 21 mg nicotine patches [<a href="#rid118">118</a>]. At six months, the biochemically verified smoking cessation rates were modest among all groups (7 versus 4 versus 6 percent, respectively), and did not differ significantly. Observed quit rates were lower than in most clinical trials, suggesting the study may have had selection bias or other methodologic issues.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a 2021 systematic review including 61 trials (of which 34 were randomized controlled trials) and over 16,000 participants, there was moderate-certainty evidence that, among those who smoke conventional cigarettes, quit rates were higher with the use of nicotine e-cigarettes compared with NRT (RR 1.53, 95% CI 1.21-1.93), and that quit rates were higher with the use of nicotine e-cigarettes compared with non-nicotine e-cigarettes (RR 1.94, 95% CI 1.21-23.13); the certainty of all evidence was limited by imprecision [<a href="#rid113">113</a>].</p><p></p><p>Observational trials provide evidence on how these devices are being used in actual practice rather than in clinical trials. Results from observational studies are mixed [<a href="#rid119">119-128</a>]. Some studies suggest an association between e-cigarette use and smoking cessation or reduction [<a href="#rid129">129</a>]. However, multiple earlier studies have suggested that e-cigarette use is not associated with higher rates of quitting or reducing smoking [<a href="#rid119">119,123,130,131</a>].</p><p class="headingAnchor" id="H28394420"><span class="h2">Smoking reduction</span><span class="headingEndMark"> — </span>An individual will gain the most benefit if smoking is stopped entirely. However, e-cigarettes might have the potential to reduce harm from tobacco-related diseases by replacing or reducing conventional cigarette use [<a href="#rid132">132-134</a>]. There is little evidence to support this hypothesis, and the degree to which smoking reduction must be achieved is not established.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Replacing conventional cigarettes</strong> – The primary benefit hypothesized is a reduction in the negative health consequences of conventional cigarette use for those who switch completely to e-cigarettes. This could decrease conventional smoking rates at the population level and should lead to a reduction in tobacco-attributable morbidity and mortality. Theoretically, the reduction in tobacco-attributed morbidity and mortality could be offset by any long-term adverse effects of e-cigarettes. (See <a class="local">'Adverse health effects'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dual use</strong> – If e-cigarettes lead to dual use (with conventional cigarettes), the individual might still reduce their tobacco-attributable risk of chronic disease if they reduce the number of conventional cigarettes smoked. However, the relationship between the amount of conventional cigarette smoking and disease is not strictly linear for all conditions. For example, small amounts of smoke exposure can still increase risk for coronary artery disease [<a href="#rid135">135</a>]. (See  <a class="medical medical_review" href="/d/html/4640.html" rel="external">"Cigarette smoking and other possible risk factors for lung cancer", section on 'Smoking reduction'</a> and  <a class="medical medical_review" href="/d/html/16706.html" rel="external">"Benefits and consequences of smoking cessation", section on 'Questionable utility of smoking reduction'</a>.)</p><p></p><p class="headingAnchor" id="H28394426"><span class="h1">PUBLIC HEALTH CONCERNS</span><span class="headingEndMark"> — </span>In 2019, cases of e-cigarette or vaping product use associated lung injury (EVALI) were reported. After epidemiologic investigation, evidence linked these cases primarily to vaping tetrahydrocannabinol (THC) products that had been contaminated with vitamin E acetate rather than to the use of commercially sold nicotine-containing e-cigarettes. (See  <a class="medical medical_review" href="/d/html/122671.html" rel="external">"E-cigarette or vaping product use-associated lung injury (EVALI)"</a>.)</p><p>Other potential impacts of e-cigarettes on public health include concerns include e-cigarettes' appeal to youth, their potential to reverse gains in social norms about the acceptability of cigarette smoking ("renormalization"), and the risk of dependence [<a href="#rid1">1,136</a>]. However, dependence appears to be lower than for conventional tobacco cigarettes [<a href="#rid1">1</a>].</p><p>In addition, there have been increasing reports of poisoning in children related to e-cigarettes and concerns about the possible effects of secondhand exposure to the aerosol. A US Surgeon General’s report about the risks of e-cigarettes to youth highlights the importance of preventing the initiation of nicotine use by adolescents [<a href="#rid105">105</a>].</p><p class="headingAnchor" id="H1032354972"><span class="h2">Renormalization of smoking behavior</span><span class="headingEndMark"> — </span>If e-cigarettes are allowed where cigarette smoking is not, they could reverse the "de-normalization" of smoking behavior brought about by the spread of smoke-free laws [<a href="#rid2">2,137</a>]. These laws are credited with contributing to reducing smoking prevalence in the United States. Tobacco smoking could be "renormalized" and the public health gains rolled back [<a href="#rid138">138</a>]. In theory, this might discourage the frequency and success of quit attempts, encourage relapse among those who previously smoked, and increase tobacco use initiation rates among youth and young adults. At present, there is no evidence of smoking renormalization.</p><p class="headingAnchor" id="H98531159"><span class="h2">Nicotine poisoning</span><span class="headingEndMark"> — </span>E-cigarette fluid contains highly concentrated liquid nicotine. Exploratory ingestions in young children and intentional ingestions in adolescents and adults have been associated with life-threatening toxicity and death. The clinical manifestations and initial management of nicotine poisoning are provided in a rapid overview (<a class="graphic graphic_table graphicRef138390" href="/d/graphic/138390.html" rel="external">table 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/130609.html" rel="external">"Nicotine poisoning (e-cigarettes, tobacco products, plants, and pesticides)"</a>.)</p><p class="headingAnchor" id="H1032354978"><span class="h2">Secondhand aerosol exposure</span><span class="headingEndMark"> — </span>There are concerns about the potential health consequences of secondhand exposure to e-cigarette aerosol due to increases in environmental concentrations of nicotine and particulate matter [<a href="#rid1">1</a>]. However, passive exposure to e-cigarette aerosol is expected to be less toxic to bystanders than conventional cigarette smoke [<a href="#rid1">1,139,140</a>]. Aerosol released from e-cigarettes will depend on user technique, temperature, e-cigarette device, and other factors [<a href="#rid141">141</a>].</p><p>There is limited evidence on the health effects of passive e-cigarette aerosol exposure. Passive exposure to aerosol produces small increases in serum cotinine, comparable with that from passive exposure to cigarette smoke [<a href="#rid142">142</a>]. (See <a class="local">'Aerosol (also known as vapor) exposure'</a> above.)</p><p class="headingAnchor" id="H28394432"><span class="h1">REGULATORY STATUS</span><span class="headingEndMark"> — </span>Regulation of e-cigarettes varies by country and is continually evolving. Multiple organizations have recommended more government regulation [<a href="#rid104">104,106,143-146</a>]. They have called for regulation that would treat e-cigarettes like conventional cigarettes, banning their use where conventional cigarettes are banned and subjecting e-cigarettes' content, sales, and marketing to regulatory constraints similar to those that apply to conventional cigarettes. Some have suggested that taxation for e-cigarettes should be lower than for conventional cigarettes to encourage adults who smoke conventional cigarettes to switch to e-cigarettes for harm reduction [<a href="#rid147">147</a>].</p><p class="headingAnchor" id="H1102660158"><span class="h2">Worldwide</span><span class="headingEndMark"> — </span>The World Health Organization (WHO) report on e-cigarettes suggested that regulations were needed to stop promotion of e-cigarettes to nonsmokers and young people, minimize potential health risks to users and nonusers, stop unproven health claims about e-cigarettes, and protect existing tobacco control efforts [<a href="#rid143">143</a>]. While the WHO acknowledged that additional research on e-cigarettes was needed, it also emphasized the need to restrict e-cigarette advertising and indoor use. Some groups have disagreed with the WHO report, suggesting that the risks of e-cigarettes were overstated [<a href="#rid148">148,149</a>].</p><p class="headingAnchor" id="H1191877483"><span class="h2">United Kingdom</span><span class="headingEndMark"> — </span>In the United Kingdom, the Royal College of Physicians Tobacco Advisory Group recommended a balanced regulatory approach that ensures product safety while enabling and encouraging those who smoke to use e-cigarettes instead of tobacco to reduce harm to health [<a href="#rid150">150</a>]. The report suggests that while e-cigarettes are not harmless, they are likely less harmful than conventional cigarettes [<a href="#rid151">151</a>].</p><p class="headingAnchor" id="H1102660152"><span class="h2">United States</span><span class="headingEndMark"> — </span>The US Food and Drug Administration (FDA) does not regulate e-cigarettes as medical products through the Center for Drug Evaluation and Policy (CDER), which regulates nicotine replacement products such as nicotine patches. E-cigarette manufacturers could apply to CDER for approval to market the devices as smoking cessation aids, but no manufacturer has yet done so.</p><p>Instead, the FDA regulates e-cigarettes through its Center for Tobacco Products (CTP). Initially, the 2009 Family Smoking Prevention and Tobacco Control Act granted the CTP the authority to regulate cigarettes and smokeless tobacco but not other tobacco products, including cigars and e-cigarettes [<a href="#rid152">152</a>]. In 2016, the regulation was amended to include any product "made or derived from tobacco that is intended for human consumption," including e-cigarettes that contain nicotine but not e-cigarettes that are nicotine-free [<a href="#rid153">153</a>].</p><p>FDA regulations require that e-cigarette manufacturers demonstrate that their products meet the FDA standard of providing a net public health benefit or face the possibility of being removed from the market [<a href="#rid154">154</a>]. The FDA voluntarily delayed enforcement of this standard while it developed a process for conducting these evaluations. It required manufacturers to submit an application for approval of e-cigarette products by September, 2020 [<a href="#rid154">154</a>]. In September 2021, the FDA announced that it had acted on over 90 percent of applications, issuing denials to over 900,000 flavored products due to health concerns related to their popularity among youth [<a href="#rid155">155</a>]. Subsequently, in October 2021, the FDA for the first time authorized the marketing of some electronic nicotine delivery system (ENDS) products, while noting that this ruling “does not mean these products are safe or ‘FDA approved’” [<a href="#rid156">156</a>].</p><p>The FDA also requires manufacturers, and in many cases retailers ("vape shops") where e-cigarette devices are modified and sold, to disclose the ingredients in their products and demonstrate that they are safe [<a href="#rid157">157,158</a>].</p><p>The FDA prohibits the sale of tobacco and e-cigarette products to those aged &lt;21 years, sales in vending machines (except in adult-only venues), and distribution of free samples [<a href="#rid159">159</a>]. In addition, there are federal regulations to minimize the risk of exposure of youth to e-cigarettes, including prohibition of sales of flavored liquids (other than menthol or tobacco) in devices that use pre-filled cartridges [<a href="#rid160">160,161</a>]. Flavored e-cigarette liquids, however, are available for sale in vape shops for use in devices that have refillable tanks. In addition, this ban did not apply to flavored disposable e-cigarettes, which have become increasingly popular among youth. Among high school e-cigarette users, for example, the percentage who reported using disposable e-cigarettes increased from 2.4 percent in 2019 to 26.5 percent in 2020 [<a href="#rid14">14</a>]. The FDA has attempted to remove these flavored disposable e-cigarettes from the market but, despite this effort, many remain on the market [<a href="#rid162">162,163</a>].</p><p>A number of states and many municipalities have banned the use of e-cigarettes in areas where cigarette smoking is also completely banned (with limited exceptions in a few states), and additional states and municipalities have banned e-cigarette use in other venues [<a href="#rid164">164</a>]. E-cigarette use is also banned on airplanes [<a href="#rid165">165</a>].</p><p class="headingAnchor" id="H1844511842"><span class="h2">Other countries</span><span class="headingEndMark"> — </span>E-cigarettes have been banned in some countries [<a href="#rid58">58</a>]. In Europe, the European Parliament approved a directive that regulates nicotine-containing e-cigarettes with concentrations up to 20 mg/mL as tobacco products [<a href="#rid166">166</a>]. E-cigarettes with higher nicotine concentrations are regulated as medical devices. The directive includes regulation for the maximum amount of nicotine in e-cigarette liquids and requires child tamper-proof packaging.</p><p class="headingAnchor" id="H28394438"><span class="h1">COUNSELING FOR PATIENTS</span><span class="headingEndMark"> — </span>In the absence of clear outcomes data on the health consequences of e-cigarette use and their efficacy for smoking cessation, evidence-based definitive recommendations cannot be made [<a href="#rid167">167</a>].</p><p>Information for counseling patients on what is known related to e-cigarettes is available from some medical societies’ documents on e-cigarettes. Policy statements from the American Cancer Society, American Heart Association, and other groups provide guidance on addressing e-cigarette use in clinical practice [<a href="#rid144">144,145,168-170</a>]. The Centers for Disease Control and Prevention (CDC) also provides guidance to clinicians and the public about electronic cigarettes [<a href="#rid171">171</a>].</p><p>For children, a report by the Surgeon General, “Know the risks, e-cigarettes and young people,” includes <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fe-cigarettes.surgeongeneral.gov%2Fdocuments%2FSGR_E-Cig_Health_Care_Provider_Card_508.pdf&amp;token=R1WZpItpOX%2FEWalnxVzlryZhkZpG9zrecrHJvABTOcr8WxLpGT0ziTyg1t2AkXV%2FrcfIM4oZ1EhbPodY7HRO71VRobKDbcvRIAoPi5%2B8UBV1h%2BZPxEb4%2FUbSmsFkY5WO&amp;TOPIC_ID=98400" target="_blank">information sheets</a> that clinicians may use to educate patients as well as a <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fe-cigarettes.surgeongeneral.gov%2Fdocuments%2FSGR_ECig_ParentTipSheet_508.pdf&amp;token=meyw%2FbEz1acg52FSpZSaiSHrp5M%2B1P7bHTAi9Z7TYfdrIC0HcLjmBjWFTEZHr4U2yhbI%2BD0SZkyGoGnpYprG34TtH7AgTsQu7nbiUmJdBN9MQJVzecm7rmLwJD3S4OX2&amp;TOPIC_ID=98400" target="_blank">tip sheet for parents</a> [<a href="#rid105">105</a>]. Information for adolescents and their caregivers about e-cigarettes is available from the CDC website, including content about <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Ftobacco%2Fbasic_information%2Fe-cigarettes%2FQuick-Facts-on-the-Risks-of-E-cigarettes-for-Kids-Teens-and-Young-Adults.html&amp;token=zS7cgtbiydNtrKMjaILnoVn3JZ%2B%2FVsnBrWYgAK9S73bAt27NFr867Cqx2%2FFOn%2FWt80kuuXwDfwOEHIaWTJJFhxWXzwOMBWlaxyg4VXYiyr8CffVmOmEbvEtOpIbJ4Dt2OK5zOS3Cqq%2F8oAsECQumhulCIYpgIJ1wLCnI%2BA4ymQc%3D&amp;TOPIC_ID=98400" target="_blank">health risks and other frequently asked questions</a> and advice for caregivers on how to <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Ftobacco%2Ffeatures%2Fback-to-school%2Findex.html&amp;token=UO9nad7M82PRUlbR4iISZcKPHRvQZ0Somy3Mh%2FxSs80yZmezbjuJYyBTtyo8qnZBpwZncZYNbUMjjbE9i0Jdu6aoiyTPxd36EqOKpZZM4yI%3D&amp;TOPIC_ID=98400" target="_blank">keep kids e-cigarette-free</a> [<a href="#rid172">172</a>].</p><p>Given the available evidence, we discuss these points with patients in a conversation about e-cigarettes:</p><p class="bulletIndent1"><span class="glyph">●</span>Recreational use of e-cigarettes should not be initiated; non-smokers should <strong>not</strong> start using or use e-cigarettes [<a href="#rid173">173</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For those who smoke combustible tobacco products, a complete switch to using nicotine-containing e-cigarettes is likely to be less harmful, but the health risks of long-term e-cigarette use are not yet known. Therefore, those who switch to e-cigarettes should eventually plan to quit e-cigarette use as well, so long as that does not lead to relapse (ie, smoking combustible cigarettes). Dual use of combustible cigarettes and e-cigarettes is <strong>not </strong>likely to substantially reduce the risk of tobacco-related disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>E-cigarette or vaping product use associated lung injury (EVALI) has been associated with vaping of tetrahydrocannabinol (THC) products contaminated by vitamin E acetate rather than commercially purchased nicotine-containing e-cigarettes. E-cigarette products should not be bought “off the street,” adulterated, or altered (ie, should not have any substances added to the commercially manufactured product) [<a href="#rid60">60</a>]. (See  <a class="medical medical_review" href="/d/html/122671.html" rel="external">"E-cigarette or vaping product use-associated lung injury (EVALI)"</a>.)</p><p></p><p>For those who smoke conventional cigarettes who are interested in using e-cigarettes for smoking cessation, we also discuss the following:</p><p class="bulletIndent1"><span class="glyph">●</span>No e-cigarette has been approved by the US Food and Drug Administration (FDA) for smoking cessation, and the FDA has not endorsed their safety or efficacy for smoking cessation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>People should be congratulated on their interest in smoking cessation and reminded that safe and effective treatments to help them reach that goal already exist.</p><p></p><p class="bulletIndent1">Individuals should be encouraged to try the FDA-approved products first because of the lack of evidence regarding the practical effectiveness of e-cigarettes in promoting smoking cessation. Those who previously failed conventional treatments should be assessed for proper medication use and/or consider second-line therapies. (See  <a class="medical medical_review" href="/d/html/16635.html" rel="external">"Pharmacotherapy for smoking cessation in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If individuals are unwilling to use FDA-approved medications for smoking cessation, it is up to the clinician's judgment whether to support the use of e-cigarettes. Smokers should be made aware of the uncertainty about their safety and efficacy as therapeutic devices. People who choose to use e-cigarettes to quit should be advised to switch completely to e-cigarettes and use them regularly as substitutes for tobacco cigarettes, rather than using e-cigarettes while continuing to smoke tobacco cigarettes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Regardless of the method chosen, it is important for the individual to understand that their efforts to become smoke-free will continue to receive the clinician's strongest support and assistance.</p><p></p><p>The use of e-cigarettes should not be permitted in hospitals or health care facilities. Conventional cigarettes are not allowed in these venues. Nicotine replacement products, not e-cigarettes, should be used to manage nicotine withdrawal symptoms in hospitalized patients. (See  <a class="medical medical_review" href="/d/html/16635.html" rel="external">"Pharmacotherapy for smoking cessation in adults", section on 'Nicotine replacement therapy'</a> and  <a class="medical medical_review" href="/d/html/16635.html" rel="external">"Pharmacotherapy for smoking cessation in adults", section on 'Hospitalized patients'</a>.)</p><p class="headingAnchor" id="H4243570423"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/109347.html" rel="external">"Society guideline links: Smoking cessation, e-cigarettes, and tobacco control"</a>.)</p><p class="headingAnchor" id="H1897626165"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/131232.html" rel="external">"Patient education: Vaping (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H28394444"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>E-cigarette devices and liquids</strong> – Electronic cigarettes (e-cigarettes) are electronic devices that usually deliver nicotine; they consist of a cartridge containing a liquid, an atomizer (vaporization chamber with a heating element), and a battery. The user activates the atomizer, which heats the liquid and produces an aerosol (sometimes referred to as a vapor) to inhale (<a class="graphic graphic_figure graphicRef98585" href="/d/graphic/98585.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef126552" href="/d/graphic/126552.html" rel="external">figure 2</a>). Across all brands, the main components in nicotine e-cigarette liquids are nicotine, propylene glycol or glycerol, and flavorings. A variety of other compounds have also been identified. (See <a class="local">'Electronic nicotine delivery systems'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevalence and patterns of use</strong> – The use of e-cigarettes by adults has increased over the past decade, and while it had more significantly increased among middle and high school students, the prevalence of use among youth appears to be declining. Most adult e-cigarette users also currently smoke conventional tobacco cigarettes. A majority of e-cigarette users perceive them to be a tool to quit or reduce their smoking. (See <a class="local">'Prevalence and patterns of use'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adverse health effects</strong> – Potential adverse effects of e-cigarettes are related to exposure to nicotine as well as to other aerosol components produced by the devices and risks of the actual device. No observational data examining the long-term risk of cancer from e-cigarettes exist; however, the risk is likely to be much lower in adults who use e-cigarettes than in those who smoke conventional cigarettes. (See <a class="local">'Adverse health effects'</a> above.)</p><p></p><p class="bulletIndent1">In 2019, the Centers for Disease Control and Prevention (CDC) reported over two thousand cases of severe acute lung illnesses (e-cigarette, or vaping, product use associated lung injury [EVALI]) linked to the use of e-cigarette devices to aerosolize substances for inhalation. Vitamin E acetate has been linked to EVALI, although the exact cause has yet to be determined. (See <a class="local">'Aerosol (also known as vapor) exposure'</a> above and  <a class="medical medical_review" href="/d/html/122671.html" rel="external">"E-cigarette or vaping product use-associated lung injury (EVALI)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of e-cigarettes in smoking cessation</strong> – For adults, the evidence that e-cigarettes are effective smoking cessation aids is growing, but the risks remain uncertain. Clinicians should encourage adults who inquire about quitting smoking to use smoking cessation aids approved by the US Food and Drug Administration (FDA), including pharmacotherapy as a first choice. For adults who have quit smoking but are using e-cigarettes, clinicians should strongly advise them not to return to smoking cigarettes but might consider offering nicotine replacement products as alternatives if the individual wishes to stop using e-cigarettes. (See <a class="local">'Role in smoking cessation'</a> above and <a class="local">'Counseling for patients'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Public health concerns</strong> – Public health concerns regarding e-cigarettes include EVALI as well as the potential to increase youth initiation of tobacco products (<a class="graphic graphic_figure graphicRef126349" href="/d/graphic/126349.html" rel="external">figure 3</a> and <a class="graphic graphic_figure graphicRef126348" href="/d/graphic/126348.html" rel="external">figure 4</a>), renormalize tobacco use in places where cigarette smoking is not acceptable, and lead to nicotine dependence. Accidental nicotine poisoning in children has been reported. The health effects of secondhand aerosol exposure are unknown. (See <a class="local">'Concerns related to youth and nonsmokers'</a> above and <a class="local">'Public health concerns'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patient counseling</strong> – Recreational use of e-cigarettes should not be initiated; non-smokers should <strong>not</strong> start using or use e-cigarettes. E-cigarette products should not be bought "off the street," adulterated, or altered (ie, should not have any substances added to the commercially manufactured product). (See <a class="local">'Counseling for patients'</a> above.)</p><p></p><p class="headingAnchor" id="H28394452"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Stephen Rennard, MD, and Sara Kalkhoran, MD, MAS, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">National Academies of Sciences, Engineering, and Medicine. Public health consequences of e-cigarettes. The National Academies Press 2018. Available at: https://www.nap.edu/catalog/24952/public-health-consequences-of-e-cigarettes (Accessed on August 14, 2020).</li><li><a class="nounderline abstract_t">Hajek P, Etter JF, Benowitz N, et al. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 2014; 109:1801.</a></li><li class="breakAll">Tozzi J, Bachman J. Big tobacco keeps pushing into e-cigarettes. Business Week, June 2014. Available at: https://www.bloomberg.com/news/articles/2014-06-17/big-tobacco-keeps-pushing-into-e-cigarettes (Accessed on December 02, 2014).</li><li><a class="nounderline abstract_t">Dinakar C, O'Connor GT. The Health Effects of Electronic Cigarettes. N Engl J Med 2016; 375:1372.</a></li><li><a class="nounderline abstract_t">Qasim H, Karim ZA, Rivera JO, et al. Impact of Electronic Cigarettes on the Cardiovascular System. J Am Heart Assoc 2017; 6.</a></li><li><a class="nounderline abstract_t">Gotts JE, Jordt SE, McConnell R, Tarran R. What are the respiratory effects of e-cigarettes? BMJ 2019; 366:l5275.</a></li><li><a class="nounderline abstract_t">Eisenberg MJ, Hébert-Losier A, Windle SB, et al. Effect of e-Cigarettes Plus Counseling vs Counseling Alone on Smoking Cessation: A Randomized Clinical Trial. JAMA 2020; 324:1844.</a></li><li><a class="nounderline abstract_t">Sindelar JL. Regulating Vaping - Policies, Possibilities, and Perils. N Engl J Med 2020; 382:e54.</a></li><li><a class="nounderline abstract_t">Hartmann-Boyce J, Begh R, Aveyard P. Electronic cigarettes for smoking cessation. BMJ 2018; 360:j5543.</a></li><li><a class="nounderline abstract_t">Krishnan-Sarin S, Morean M, Kong G, et al. E-Cigarettes and "Dripping" Among High-School Youth. Pediatrics 2017; 139.</a></li><li><a class="nounderline abstract_t">Barrington-Trimis JL, Leventhal AM. Adolescents' Use of "Pod Mod" E-Cigarettes - Urgent Concerns. N Engl J Med 2018; 379:1099.</a></li><li><a class="nounderline abstract_t">Ali FRM, Diaz MC, Vallone D, et al. E-cigarette Unit Sales, by Product and Flavor Type - United States, 2014-2020. MMWR Morb Mortal Wkly Rep 2020; 69:1313.</a></li><li class="breakAll">Aubrey A. Parents: Teens are still vaping, despite flavor ban. Here's what they're using. National Public Radio, February 2020. Available at: https://www.npr.org/sections/health-shots/2020/02/17/805972087/teens-are-still-vaping-flavors-thanks-to-new-disposable-vape-pens (Accessed on March 30, 2021).</li><li><a class="nounderline abstract_t">Wang TW, Neff LJ, Park-Lee E, et al. E-cigarette Use Among Middle and High School Students - United States, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:1310.</a></li><li><a class="nounderline abstract_t">Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014; 23:133.</a></li><li><a class="nounderline abstract_t">Williams M, Villarreal A, Bozhilov K, et al. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 2013; 8:e57987.</a></li><li><a class="nounderline abstract_t">Kim HJ, Shin HS. Determination of tobacco-specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatography-tandem mass spectrometry. J Chromatogr A 2013; 1291:48.</a></li><li><a class="nounderline abstract_t">Ward AM, Yaman R, Ebbert JO. Electronic nicotine delivery system design and aerosol toxicants: A systematic review. PLoS One 2020; 15:e0234189.</a></li><li><a class="nounderline abstract_t">Jackler RK, Ramamurthi D. Nicotine arms race: JUUL and the high-nicotine product market. Tob Control 2019; 28:623.</a></li><li><a class="nounderline abstract_t">Harvanko AM, Havel CM, Jacob P, Benowitz NL. Characterization of Nicotine Salts in 23 Electronic Cigarette Refill Liquids. Nicotine Tob Res 2020; 22:1239.</a></li><li><a class="nounderline abstract_t">Hutzler C, Paschke M, Kruschinski S, et al. Chemical hazards present in liquids and vapors of electronic cigarettes. Arch Toxicol 2014; 88:1295.</a></li><li><a class="nounderline abstract_t">Zhu SH, Sun JY, Bonnevie E, et al. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control 2014; 23 Suppl 3:iii3.</a></li><li class="breakAll">Centers for Disease Control and Prevention. 2016 Surgeon General's report: E-cigarette use among youth and young adults. Available at: https://www.cdc.gov/tobacco/data_statistics/sgr/e-cigarettes/index.htm (Accessed on September 11, 2018).</li><li><a class="nounderline abstract_t">Olmedo P, Goessler W, Tanda S, et al. Metal Concentrations in e-Cigarette Liquid and Aerosol Samples: The Contribution of Metallic Coils. Environ Health Perspect 2018; 126:027010.</a></li><li><a class="nounderline abstract_t">Zhao D, Aravindakshan A, Hilpert M, et al. Metal/Metalloid Levels in Electronic Cigarette Liquids, Aerosols, and Human Biosamples: A Systematic Review. Environ Health Perspect 2020; 128:36001.</a></li><li><a class="nounderline abstract_t">Trehy ML, Ye W, Hadwiger ME, et al. Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities. J Liq Chromatogr Relat Technol 2011; 34:1442.</a></li><li><a class="nounderline abstract_t">Goniewicz ML, Smith DM, Edwards KC, et al. Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes. JAMA Netw Open 2018; 1:e185937.</a></li><li class="breakAll">US Food and Drug Administration. FDA authorizes marketing of IQOS tobacco heating system with 'reduced exposure' information. 2020. Available at: https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-iqos-tobacco-heating-system-reduced-exposure-information (Accessed on August 14, 2020).</li><li><a class="nounderline abstract_t">Bao W, Liu B, Du Y, et al. Electronic Cigarette Use Among Young, Middle-aged, and Older Adults in the United States in 2017 and 2018. JAMA Intern Med 2020; 180:313.</a></li><li><a class="nounderline abstract_t">Dai H, Leventhal AM. Prevalence of e-Cigarette Use Among Adults in the United States, 2014-2018. JAMA 2019; 322:1824.</a></li><li><a class="nounderline abstract_t">Cornelius ME, Wang TW, Jamal A, et al. Tobacco Product Use Among Adults - United States, 2019. MMWR Morb Mortal Wkly Rep 2020; 69:1736.</a></li><li><a class="nounderline abstract_t">Cornelius ME, Loretan CG, Wang TW, et al. Tobacco Product Use Among Adults - United States, 2020. MMWR Morb Mortal Wkly Rep 2022; 71:397.</a></li><li><a class="nounderline abstract_t">Cornelius ME, Loretan CG, Jamal A, et al. Tobacco Product Use Among Adults - United States, 2021. MMWR Morb Mortal Wkly Rep 2023; 72:475.</a></li><li><a class="nounderline abstract_t">Jamal A, Gentzke A, Hu SS, et al. Tobacco Use Among Middle and High School Students - United States, 2011-2016. MMWR Morb Mortal Wkly Rep 2017; 66:597.</a></li><li><a class="nounderline abstract_t">Miech R, Johnston L, O'Malley PM, et al. Trends in Adolescent Vaping, 2017-2019. N Engl J Med 2019; 381:1490.</a></li><li class="breakAll">Wang TW, Gentzke AS, Creamer MR, et al. Tobacco Product Use and Associated Factors Among Middle and High School Students-United States 2019. MMWR Surveillance Summary; CDC, 2019.</li><li><a class="nounderline abstract_t">Gentzke AS, Wang TW, Cornelius M, et al. Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021. MMWR Surveill Summ 2022; 71:1.</a></li><li><a class="nounderline abstract_t">Park-Lee E, Ren C, Cooper M, et al. Tobacco Product Use Among Middle and High School Students - United States, 2022. MMWR Morb Mortal Wkly Rep 2022; 71:1429.</a></li><li class="breakAll">Villaroel MA, Cha AE, Vahratian A. National Center for Health Statistics. Electronic cigarette use among US adults, 2018. US Department of Health and Human Services 2020. Available at: https://www.cdc.gov/nchs/data/databriefs/db365-h.pdf (Accessed on August 14, 2020).</li><li><a class="nounderline abstract_t">Wang TW, Gentzke A, Sharapova S, et al. Tobacco Product Use Among Middle and High School Students - United States, 2011-2017. MMWR Morb Mortal Wkly Rep 2018; 67:629.</a></li><li><a class="nounderline abstract_t">Mayer M, Reyes-Guzman C, Grana R, et al. Demographic Characteristics, Cigarette Smoking, and e-Cigarette Use Among US Adults. JAMA Netw Open 2020; 3:e2020694.</a></li><li><a class="nounderline abstract_t">Cullen KA, Gentzke AS, Sawdey MD, et al. e-Cigarette Use Among Youth in the United States, 2019. JAMA 2019; 322:2095.</a></li><li><a class="nounderline abstract_t">Mirbolouk M, Charkhchi P, Kianoush S, et al. Prevalence and Distribution of E-Cigarette Use Among U.S. Adults: Behavioral Risk Factor Surveillance System, 2016. Ann Intern Med 2018; 169:429.</a></li><li><a class="nounderline abstract_t">Coleman BN, Rostron B, Johnson SE, et al. Electronic cigarette use among US adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014. Tob Control 2017; 26:e117.</a></li><li><a class="nounderline abstract_t">Delnevo CD, Giovenco DP, Steinberg MB, et al. Patterns of Electronic Cigarette Use Among Adults in the United States. Nicotine Tob Res 2016; 18:715.</a></li><li class="breakAll">Action on Smoking and Health. Use of e-cigarettes (vaporisers) among adults in Great Britain. 2019. Available at: https://ash.org.uk/wp-content/uploads/2019/09/Use-of-e-cigarettes-among-adults-2019.pdf (Accessed on August 14, 2020).</li><li><a class="nounderline abstract_t">Kalkhoran S, Alvarado N, Vijayaraghavan M, et al. Patterns of and reasons for electronic cigarette use in primary care patients. J Gen Intern Med 2017; 32:1122.</a></li><li><a class="nounderline abstract_t">Patel D, Davis KC, Cox S, et al. Reasons for current E-cigarette use among U.S. adults. Prev Med 2016; 93:14.</a></li><li><a class="nounderline abstract_t">Berg CJ, Haardoerfer R, Escoffery C, et al. Cigarette users' interest in using or switching to electronic nicotine delivery systems for smokeless tobacco for harm reduction, cessation, or novelty: a cross-sectional survey of US adults. Nicotine Tob Res 2015; 17:245.</a></li><li><a class="nounderline abstract_t">Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res 2013; 15:267.</a></li><li><a class="nounderline abstract_t">DeVito EE, Krishnan-Sarin S. E-cigarettes: Impact of E-Liquid Components and Device Characteristics on Nicotine Exposure. Curr Neuropharmacol 2018; 16:438.</a></li><li><a class="nounderline abstract_t">Farsalinos KE, Romagna G, Tsiapras D, et al. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Subst Abuse 2013; 7:139.</a></li><li><a class="nounderline abstract_t">Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl) 2014; 231:401.</a></li><li><a class="nounderline abstract_t">Shahab L, Goniewicz ML, Blount BC, et al. Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study. Ann Intern Med 2017; 166:390.</a></li><li><a class="nounderline abstract_t">St Helen G, Havel C, Dempsey DA, et al. Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. Addiction 2016; 111:535.</a></li><li><a class="nounderline abstract_t">Schroeder MJ, Hoffman AC. Electronic cigarettes and nicotine clinical pharmacology. Tob Control 2014; 23 Suppl 2:ii30.</a></li><li><a class="nounderline abstract_t">Goniewicz ML, Kuma T, Gawron M, et al. Nicotine levels in electronic cigarettes. Nicotine Tob Res 2013; 15:158.</a></li><li><a class="nounderline abstract_t">Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation 2014; 129:1972.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Severe pulmonary disease associated with using e-cigarette products. August 2019. Available at: https://emergency.cdc.gov/han/han00421.asp (Accessed on September 23, 2019).</li><li class="breakAll">Centers for Disease Control and Prevention. Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. Available at: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html#what-is-new (Accessed on November 21, 2019).</li><li><a class="nounderline abstract_t">Blount BC, Karwowski MP, Morel-Espinosa M, et al. Evaluation of Bronchoalveolar Lavage Fluid from Patients in an Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - 10 States, August-October 2019. MMWR Morb Mortal Wkly Rep 2019; 68:1040.</a></li><li><a class="nounderline abstract_t">Chatham-Stephens K, Roguski K, Jang Y, et al. Characteristics of Hospitalized and Nonhospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, November 2019. MMWR Morb Mortal Wkly Rep 2019; 68:1076.</a></li><li><a class="nounderline abstract_t">Krishnasamy VP, Hallowell BD, Ko JY, et al. Update: Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, August 2019-January 2020. MMWR Morb Mortal Wkly Rep 2020; 69:90.</a></li><li><a class="nounderline abstract_t">Werner AK, Koumans EH, Chatham-Stephens K, et al. Hospitalizations and Deaths Associated with EVALI. N Engl J Med 2020; 382:1589.</a></li><li class="breakAll">US Food and Drug Administration. Vaping illness update: FDA warns public to stop using tetrahydrocannabinol (THC)-containing vaping products and any vaping products obtained off the street. Available at: https://www.fda.gov/consumers/consumer-updates/vaping-illnesses-consumers-can-help-protect-themselves-avoiding-tetrahydrocannabinol-thc-containing (Accessed on April 22, 2022).</li><li><a class="nounderline abstract_t">Abrams DB. Promise and peril of e-cigarettes: can disruptive technology make cigarettes obsolete? JAMA 2014; 311:135.</a></li><li><a class="nounderline abstract_t">Kosmider L, Sobczak A, Fik M, et al. Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res 2014; 16:1319.</a></li><li><a class="nounderline abstract_t">Laino T, Tuma C, Moor P, et al. Mechanisms of propylene glycol and triacetin pyrolysis. J Phys Chem A 2012; 116:4602.</a></li><li><a class="nounderline abstract_t">Jensen RP, Luo W, Pankow JF, et al. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med 2015; 372:392.</a></li><li class="breakAll">Public Health England. Evidence review of e-cigarettes and heated tobacco products 2018: executive summary. Available at: https://www.gov.uk/government/publications/e-cigarettes-and-heated-tobacco-products-evidence-review/evidence-review-of-e-cigarettes-and-heated-tobacco-products-2018-executive-summary (Accessed on March 15, 2018).</li><li><a class="nounderline abstract_t">Benowitz NL, Fraiman JB. Cardiovascular effects of electronic cigarettes. Nat Rev Cardiol 2017.</a></li><li><a class="nounderline abstract_t">Moheimani RS, Bhetraratana M, Yin F, et al. Increased Cardiac Sympathetic Activity and Oxidative Stress in Habitual Electronic Cigarette Users: Implications for Cardiovascular Risk. JAMA Cardiol 2017; 2:278.</a></li><li><a class="nounderline abstract_t">Moheimani RS, Bhetraratana M, Peters KM, et al. Sympathomimetic Effects of Acute E-Cigarette Use: Role of Nicotine and Non-Nicotine Constituents. J Am Heart Assoc 2017; 6.</a></li><li><a class="nounderline abstract_t">George J, Hussain M, Vadiveloo T, et al. Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes. J Am Coll Cardiol 2019; 74:3112.</a></li><li class="breakAll">National Academies of Sciences, Engineering, and Medicine. Public health consequences of e-cigarettes. The National Academies Press 2018. Available at: https://www.nap.edu/catalog/24952/public-health-consequences-of-e-cigarettes (Accessed on March 23, 2021).</li><li><a class="nounderline abstract_t">Wang MP, Ho SY, Leung LT, Lam TH. Electronic Cigarette Use and Respiratory Symptoms in Chinese Adolescents in Hong Kong. JAMA Pediatr 2016; 170:89.</a></li><li><a class="nounderline abstract_t">McConnell R, Barrington-Trimis JL, Wang K, et al. Electronic Cigarette Use and Respiratory Symptoms in Adolescents. Am J Respir Crit Care Med 2017; 195:1043.</a></li><li><a class="nounderline abstract_t">Giovanni SP, Keller TL, Bryant AD, et al. Electronic Cigarette Use and Chronic Respiratory Symptoms among U.S. Adults. Am J Respir Crit Care Med 2020; 201:1157.</a></li><li><a class="nounderline abstract_t">Li D, Sundar IK, McIntosh S, et al. Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the Population Assessment of Tobacco and Health (PATH) study, wave 2. Tob Control 2020; 29:140.</a></li><li><a class="nounderline abstract_t">Barrington-Trimis JL, Samet JM, McConnell R. Flavorings in electronic cigarettes: an unrecognized respiratory health hazard? JAMA 2014; 312:2493.</a></li><li><a class="nounderline abstract_t">Farsalinos KE, Kistler KA, Gillman G, Voudris V. Evaluation of electronic cigarette liquids and aerosol for the presence of selected inhalation toxins. Nicotine Tob Res 2015; 17:168.</a></li><li><a class="nounderline abstract_t">Behar RZ, Davis B, Wang Y, et al. Identification of toxicants in cinnamon-flavored electronic cigarette refill fluids. Toxicol In Vitro 2014; 28:198.</a></li><li><a class="nounderline abstract_t">Hua M, Omaiye EE, Luo W, et al. Identification of Cytotoxic Flavor Chemicals in Top-Selling Electronic Cigarette Refill Fluids. Sci Rep 2019; 9:2782.</a></li><li><a class="nounderline abstract_t">Farsalinos KE, Romagna G, Allifranchini E, et al. Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health 2013; 10:5146.</a></li><li><a class="nounderline abstract_t">Bahl V, Lin S, Xu N, et al. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 2012; 34:529.</a></li><li><a class="nounderline abstract_t">Allen JG, Flanigan SS, LeBlanc M, et al. Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes. Environ Health Perspect 2016; 124:733.</a></li><li><a class="nounderline abstract_t">Kosmider L, Sobczak A, Prokopowicz A, et al. Cherry-flavoured electronic cigarettes expose users to the inhalation irritant, benzaldehyde. Thorax 2016; 71:376.</a></li><li><a class="nounderline abstract_t">Rigotti NA. Balancing the Benefits and Harms of E-Cigarettes: A National Academies of Science, Engineering, and Medicine Report. Ann Intern Med 2018; 168:666.</a></li><li><a class="nounderline abstract_t">Meernik C, Williams FN, Cairns BA, et al. Burns from e-cigarettes and other electronic nicotine delivery systems. BMJ 2016; 354:i5024.</a></li><li><a class="nounderline abstract_t">Brownson EG, Thompson CM, Goldsberry S, et al. Explosion Injuries from E-Cigarettes. N Engl J Med 2016; 375:1400.</a></li><li><a class="nounderline abstract_t">Burns injuries from e-cigarettes kept in pockets. BMJ 2019; 364:i554.</a></li><li><a class="nounderline abstract_t">Rossheim ME, McDonald KK, Soule EK, et al. Electronic cigarette explosion/burn and poisoning related emergency department visits, 2018-2019. Am J Emerg Med 2020; 38:2637.</a></li><li><a class="nounderline abstract_t">Toy J, Dong F, Lee C, et al. Alarming increase in electronic nicotine delivery systems-related burn injuries: A serious unregulated public health issue. Am J Emerg Med 2017; 35:1781.</a></li><li><a class="nounderline abstract_t">Leventhal AM, Strong DR, Kirkpatrick MG, et al. Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence. JAMA 2015; 314:700.</a></li><li><a class="nounderline abstract_t">Primack BA, Soneji S, Stoolmiller M, et al. Progression to Traditional Cigarette Smoking After Electronic Cigarette Use Among US Adolescents and Young Adults. JAMA Pediatr 2015; 169:1018.</a></li><li><a class="nounderline abstract_t">Barrington-Trimis JL, Urman R, Berhane K, et al. E-Cigarettes and Future Cigarette Use. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">Soneji S, Barrington-Trimis JL, Wills TA, et al. Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults: A Systematic Review and Meta-analysis. JAMA Pediatr 2017; 171:788.</a></li><li><a class="nounderline abstract_t">Hines JZ, Fiala SC, Hedberg K. Electronic Cigarettes as an Introductory Tobacco Product Among Eighth and 11th Grade Tobacco Users - Oregon, 2015. MMWR Morb Mortal Wkly Rep 2017; 66:604.</a></li><li><a class="nounderline abstract_t">Chan GCK, Stjepanović D, Lim C, et al. Gateway or common liability? A systematic review and meta-analysis of studies of adolescent e-cigarette use and future smoking initiation. Addiction 2021; 116:743.</a></li><li><a class="nounderline abstract_t">Soneji S. Errors in Data Input in Meta-analysis on Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults. JAMA Pediatr 2018; 172:92.</a></li><li><a class="nounderline abstract_t">Dutra LM, Glantz SA. E-cigarettes and National Adolescent Cigarette Use: 2004-2014. Pediatrics 2017; 139.</a></li><li><a class="nounderline abstract_t">Vardavas CI, Anagnostopoulos N, Kougias M, et al. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012; 141:1400.</a></li><li><a class="nounderline abstract_t">Gaiha SM, Cheng J, Halpern-Felsher B. Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19. J Adolesc Health 2020; 67:519.</a></li><li><a class="nounderline abstract_t">Walley SC, Jenssen BP, Section on Tobacco Control. Electronic Nicotine Delivery Systems. Pediatrics 2015; 136:1018.</a></li><li class="breakAll">E-cigarette use among youth and young adults: A report of the Surgeon General (2016). Available at: https://e-cigarettes.surgeongeneral.gov/documents/2016_SGR_Exec_Summ_508.pdf.</li><li><a class="nounderline abstract_t">Farber HJ, Nelson KE, Groner JA, et al. Public Policy to Protect Children From Tobacco, Nicotine, and Tobacco Smoke. Pediatrics 2015; 136:998.</a></li><li><a class="nounderline abstract_t">Winickoff JP, Winickoff SE. Potential Solutions to Electronic Cigarette Use Among Adolescents. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">Grana RA, Ling PM. "Smoking revolution": a content analysis of electronic cigarette retail websites. Am J Prev Med 2014; 46:395.</a></li><li><a class="nounderline abstract_t">Choi K, Forster JL. Beliefs and experimentation with electronic cigarettes: a prospective analysis among young adults. Am J Prev Med 2014; 46:175.</a></li><li><a class="nounderline abstract_t">Chen-Sankey JC, Unger JB, Bansal-Travers M, et al. E-cigarette Marketing Exposure and Subsequent Experimentation Among Youth and Young Adults. Pediatrics 2019; 144.</a></li><li><a class="nounderline abstract_t">Mantey DS, Cooper MR, Clendennen SL, et al. E-Cigarette Marketing Exposure Is Associated With E-Cigarette Use Among US Youth. J Adolesc Health 2016; 58:686.</a></li><li><a class="nounderline abstract_t">US Preventive Services Task Force, Krist AH, Davidson KW, et al. Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement. JAMA 2021; 325:265.</a></li><li><a class="nounderline abstract_t">Hartmann-Boyce J, McRobbie H, Butler AR, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 2021; 9:CD010216.</a></li><li><a class="nounderline abstract_t">Steinberg MB, Zimmermann MH, Delnevo CD, et al. E-cigarette versus nicotine inhaler: comparing the perceptions and experiences of inhaled nicotine devices. J Gen Intern Med 2014; 29:1444.</a></li><li><a class="nounderline abstract_t">Leone FT, Zhang Y, Evers-Casey S, et al. Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2020; 202:e5.</a></li><li><a class="nounderline abstract_t">Hajek P, Phillips-Waller A, Przulj D, et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. N Engl J Med 2019; 380:629.</a></li><li><a class="nounderline abstract_t">Rigotti NA. Randomized Trials of e-Cigarettes for Smoking Cessation. JAMA 2020; 324:1835.</a></li><li><a class="nounderline abstract_t">Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013; 382:1629.</a></li><li><a class="nounderline abstract_t">Adkison SE, O'Connor RJ, Bansal-Travers M, et al. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med 2013; 44:207.</a></li><li><a class="nounderline abstract_t">Polosa R, Caponnetto P, Morjaria JB, et al. Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 2011; 11:786.</a></li><li><a class="nounderline abstract_t">Polosa R, Morjaria JB, Caponnetto P, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med 2014; 9:537.</a></li><li><a class="nounderline abstract_t">Popova L, Ling PM. Alternative tobacco product use and smoking cessation: a national study. Am J Public Health 2013; 103:923.</a></li><li><a class="nounderline abstract_t">Grana RA, Popova L, Ling PM. A longitudinal analysis of electronic cigarette use and smoking cessation. JAMA Intern Med 2014; 174:812.</a></li><li><a class="nounderline abstract_t">Brown J, Beard E, Kotz D, et al. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014; 109:1531.</a></li><li><a class="nounderline abstract_t">McQueen N, Partington EJ, Harrington KF, et al. Smoking Cessation and Electronic Cigarette Use among Head and Neck Cancer Patients. Otolaryngol Head Neck Surg 2016; 154:73.</a></li><li><a class="nounderline abstract_t">Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med 2016; 4:116.</a></li><li><a class="nounderline abstract_t">Zhu SH, Zhuang YL, Wong S, et al. E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys. BMJ 2017; 358:j3262.</a></li><li><a class="nounderline abstract_t">Gomajee R, El-Khoury F, Goldberg M, et al. Association Between Electronic Cigarette Use and Smoking Reduction in France. JAMA Intern Med 2019; 179:1193.</a></li><li><a class="nounderline abstract_t">Kalkhoran S, Chang Y, Rigotti NA. Electronic Cigarette Use and Cigarette Abstinence Over 2 Years Among U.S. Smokers in the Population Assessment of Tobacco and Health Study. Nicotine Tob Res 2020; 22:728.</a></li><li><a class="nounderline abstract_t">Al-Delaimy WK, Myers MG, Leas EC, et al. E-cigarette use in the past and quitting behavior in the future: a population-based study. Am J Public Health 2015; 105:1213.</a></li><li><a class="nounderline abstract_t">Borderud SP, Li Y, Burkhalter JE, et al. Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer 2014; 120:3527.</a></li><li><a class="nounderline abstract_t">E-cigarettes--aid to smoking cessation or smokescreen? Lancet 2014; 384:829.</a></li><li><a class="nounderline abstract_t">Drummond MB. Electronic Cigarettes: Perhaps the Devil Unknown Is Better Than the Devil Known. Ann Intern Med 2015; 163:61.</a></li><li><a class="nounderline abstract_t">Cobb CO, Foulds J, Yen MS, et al. Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial. Lancet Respir Med 2021; 9:840.</a></li><li class="breakAll">The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General, National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. (Ed), Centers for Disease Control and Prevention (US), Atlanta (GA) 2014.</li><li><a class="nounderline abstract_t">Gostin LO, Glasner AY. E-cigarettes, vaping, and youth. JAMA 2014; 312:595.</a></li><li><a class="nounderline abstract_t">Glynn TJ. E-cigarettes and the future of tobacco control. CA Cancer J Clin 2014; 64:164.</a></li><li><a class="nounderline abstract_t">Fairchild AL, Bayer R, Colgrove J. The renormalization of smoking? E-cigarettes and the tobacco "endgame". N Engl J Med 2014; 370:293.</a></li><li><a class="nounderline abstract_t">Pellegrino RM, Tinghino B, Mangiaracina G, et al. Electronic cigarettes: an evaluation of exposure to chemicals and fine particulate matter (PM). Ann Ig 2012; 24:279.</a></li><li><a class="nounderline abstract_t">Burstyn I. Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks. BMC Public Health 2014; 14:18.</a></li><li><a class="nounderline abstract_t">Schripp T, Markewitz D, Uhde E, Salthammer T. Does e-cigarette consumption cause passive vaping? Indoor Air 2013; 23:25.</a></li><li><a class="nounderline abstract_t">Farsalinos KE, Tsiapras D, Kyrzopoulos S, et al. Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovasc Disord 2014; 14:78.</a></li><li class="breakAll">WHO Framework Convention on Tobacco Control. Electronic nicotine delivery systems: Report by WHO. July 2014. Available at: http://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10-en.pdf?ua=1 (Accessed on April 22, 2022).</li><li><a class="nounderline abstract_t">Schraufnagel DE, Blasi F, Drummond MB, et al. Electronic cigarettes. A position statement of the forum of international respiratory societies. Am J Respir Crit Care Med 2014; 190:611.</a></li><li><a class="nounderline abstract_t">Brandon TH, Goniewicz ML, Hanna NH, et al. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. J Clin Oncol 2015; 33:952.</a></li><li><a class="nounderline abstract_t">Crowley RA, Health Public Policy Committee of the American College of Physicians. Electronic nicotine delivery systems: executive summary of a policy position paper from the American College of Physicians. Ann Intern Med 2015; 162:583.</a></li><li><a class="nounderline abstract_t">Chaloupka FJ, Sweanor D, Warner KE. Differential Taxes for Differential Risks--Toward Reduced Harm from Nicotine-Yielding Products. N Engl J Med 2015; 373:594.</a></li><li><a class="nounderline abstract_t">Ashton JR. Regulation of electronic cigarettes. BMJ 2014; 349:g5484.</a></li><li><a class="nounderline abstract_t">Hawkes N. WHO review exaggerated dangers of e-cigarettes, say specialists. BMJ 2014; 349:g5501.</a></li><li class="breakAll">Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. Available at: https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction-0 (Accessed on June 01, 2016).</li><li><a class="nounderline abstract_t">Britton J, Arnott D, McNeill A, et al. Nicotine without smoke-putting electronic cigarettes in context. BMJ 2016; 353:i1745.</a></li><li class="breakAll">Public Law 111-31 - June 22, 2009. Family smoking prevention and tobacco control and federal retirement reform. 111th Congress, June 2009. Available at: www.gpo.gov/fdsys/pkg/PLAW-111publ31/pdf/PLAW-111publ31.pdf (Accessed on December 03, 2014).</li><li class="breakAll">Federal Register. Deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act, as amended by the Family Smoking Prevention and Tobacco Control Act; restrictions on the sale and distribution of tobacco products and required warning statements for tobacco products. Available at: https://www.federalregister.gov/articles/2016/05/10/2016-10685/deeming-tobacco-products-to-be-subject-to-the-federal-food-drug-and-cosmetic-act-as-amended-by-the (Accessed on May 09, 2016).</li><li class="breakAll">US Food and Drug Administration. FDA denies marketing applications for about 55,00 flavored e-cigarette products for failing to provide evidence they appropriately protect public health. Available at: https://www.fda.gov/news-events/press-announcements/fda-denies-marketing-applications-about-55000-flavored-e-cigarette-products-failing-provide-evidence (Accessed on August 27, 2021).</li><li class="breakAll">US Food and Drug Administration. FDA makes significant progress in science-based public health application review, taking action on over 90% of more than 6.5 million 'deemed' new tobacco products submitted. September 2021. Available at: https://www.fda.gov/news-events/press-announcements/fda-makes-significant-progress-science-based-public-health-application-review-taking-action-over-90 (Accessed on September 24, 2021).</li><li class="breakAll">US Food and Drug Administration. FDA permits marketing of e-cigarette products, marking first authorization of its kind by the agency. October 2021. Available at: https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-e-cigarette-products-marking-first-authorization-its-kind-agency (Accessed on October 19, 2021).</li><li class="breakAll">US Food and Drug Administration. Vaporizers, e-cigarettes, and other electronic nicotine delivery systems (ENDS). Available at: https://www.fda.gov/tobacco-products/products-ingredients-components/vaporizers-e-cigarettes-and-other-electronic-nicotine-delivery-systems-ends (Accessed on January 07, 2020).</li><li class="breakAll">US Food and Drug Administration. Interpretation of and compliance policy for certain label requirement: Applicability of certain federal Food, Drug, and Cosmetic Act requirements to vape shops. March 2019. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/interpretation-and-compliance-policy-certain-label-requirement-applicability-certain-federal-food (Accessed on January 07, 2020).</li><li class="breakAll">US Food and Drug Administration. Rules for sales of e-cigarettes, e-liquids, and other electronic nicotine delivery systems (ENDS). Available at: https://www.fda.gov/tobacco-products/retail-sales-tobacco-products/selling-tobacco-products-retail-stores#ecig (Accessed on January 07, 2020).</li><li class="breakAll">https://www.fda.gov/news-events/press-announcements/fda-finalizes-enforcement-policy-unauthorized-flavored-cartridge-based-e-cigarettes-appeal-children (Accessed on January 07, 2020).</li><li class="breakAll">US Food and Drug Administration. FDA warns manufacturers and retailers to remove certain e-cigarette products targeted to youth from the market. April 2020. Available at: https://www.fda.gov/news-events/press-announcements/fda-warns-manufacturers-and-retailers-remove-certain-e-cigarette-products-targeted-youth-market (Accessed on April 27, 2020).</li><li class="breakAll">US Food and Drug Administration. FDA notifies companies, including Puff Bar, to remove flavored disposable e-cigarettes and youth-appealing e-liquids from market for not having required authorization. 2020. Available at: https://www.fda.gov/news-events/press-announcements/fda-notifies-companies-including-puff-bar-remove-flavored-disposable-e-cigarettes-and-youth (Accessed on March 04, 2021).</li><li class="breakAll">Maloney J. Puff Bar defies FDA crackdown on fruity e-cigarettes by ditching the tobacco. Wall Street Journal 2021. Available at: https://www.wsj.com/articles/puff-bar-defies-fda-crackdown-on-fruity-e-cigarettes-by-ditching-the-tobacco-11614681003 (Accessed on March 04, 2021).</li><li class="breakAll">American Nonsmokers' Rights Foundation. States and municipalities with laws regulating use of electronic cigarettes. Available at: https://no-smoke.org/wp-content/uploads/pdf/ecigslaws.pdf (Accessed on September 14, 2018).</li><li class="breakAll">US Department of Transportation. DOT issues new flight safety rule for e-cigarettes. October 2015. Available at: https://www.transportation.gov/briefing-room/dot-issues-new-flight-safety-rule-e-cigarettes (Accessed on May 20, 2016).</li><li class="breakAll">European Commission. Revision of the Tobacco Products Directive. Available at: https://ec.europa.eu/health/tobacco/product-regulation/implementing-tobacco-products-directive-directive-201440eu/revision-tobacco-products-directive_en (Accessed on December 08, 2014).</li><li class="breakAll">US Preventive Services Task Force. Final recommendation statement: Tobacco smoking cessation in adults, including pregnant women: Behavioral and pharmacotherapy interventions. Available at: https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions (Accessed on August 14, 2020).</li><li><a class="nounderline abstract_t">Bhatnagar A, Whitsel LP, Ribisl KM, et al. Electronic cigarettes: a policy statement from the American Heart Association. Circulation 2014; 130:1418.</a></li><li><a class="nounderline abstract_t">Born H, Persky M, Kraus DH, et al. Electronic Cigarettes: A Primer for Clinicians. Otolaryngol Head Neck Surg 2015; 153:5.</a></li><li class="breakAll">American Cancer Society. Position statement on electronic cigarettes. Available at: https://www.cancer.org/healthy/stay-away-from-tobacco/e-cigarette-position-statement.html (Accessed on August 14, 2020).</li><li class="breakAll">Centers for Disease Control and Prevention. Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. Available at: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html (Accessed on August 14, 2020).</li><li class="breakAll">Centers for Disease Control and Prevention. Quick facts on the risks of e-cigarettes for kids, teens, and young adults. Available at: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/Quick-Facts-on-the-Risks-of-E-cigarettes-for-Kids-Teens-and-Young-Adults.html (Accessed on August 27, 2018).</li><li class="breakAll">Centers for Disease Control and Prevention. About electronic cigarettes (e-cigarettes). Available at: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/about-e-cigarettes.html (Accessed on October 01, 2019).</li></ol></div><div id="topicVersionRevision">Topic 98400 Version 83.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.nap.edu/catalog/24952/public-health-consequences-of-e-cigarettes" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : National Academies of Sciences, Engineering, and Medicine. Public health consequences of e-cigarettes. The National Academies Press 2018. Available at: https://www.nap.edu/catalog/24952/public-health-consequences-of-e-cigarettes (Accessed on August 14, 2020).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25078252" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25078252" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27705269" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The Health Effects of Electronic Cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28855171" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Impact of Electronic Cigarettes on the Cardiovascular System.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31570493" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : What are the respiratory effects of e-cigarettes?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33170240" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Effect of e-Cigarettes Plus Counseling vs Counseling Alone on Smoking Cessation: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32212514" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Regulating Vaping - Policies, Possibilities, and Perils.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29343486" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Electronic cigarettes for smoking cessation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28167512" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : E-Cigarettes and "Dripping" Among High-School Youth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30134127" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Adolescents' Use of "Pod Mod" E-Cigarettes - Urgent Concerns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32941416" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : E-cigarette Unit Sales, by Product and Flavor Type - United States, 2014-2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32941416" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : E-cigarette Unit Sales, by Product and Flavor Type - United States, 2014-2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32941408" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : E-cigarette Use Among Middle and High School Students - United States, 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23467656" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Levels of selected carcinogens and toxicants in vapour from electronic cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23526962" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23602640" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Determination of tobacco-specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatography-tandem mass spectrometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32497139" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Electronic nicotine delivery system design and aerosol toxicants: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30733312" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Nicotine arms race: JUUL and the high-nicotine product market.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31821492" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Characterization of Nicotine Salts in 23 Electronic Cigarette Refill Liquids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24958024" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Chemical hazards present in liquids and vapors of electronic cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24935895" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24935895" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29467105" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Metal Concentrations in e-Cigarette Liquid and Aerosol Samples: The Contribution of Metallic Coils.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32186411" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Metal/Metalloid Levels in Electronic Cigarette Liquids, Aerosols, and Human Biosamples: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30646298" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30646298" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31609399" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Electronic Cigarette Use Among Young, Middle-aged, and Older Adults in the United States in 2017 and 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31524940" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Prevalence of e-Cigarette Use Among Adults in the United States, 2014-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33211681" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Tobacco Product Use Among Adults - United States, 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35298455" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Tobacco Product Use Among Adults - United States, 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37141154" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Tobacco Product Use Among Adults - United States, 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28617771" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Tobacco Use Among Middle and High School Students - United States, 2011-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31532955" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Trends in Adolescent Vaping, 2017-2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31532955" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Trends in Adolescent Vaping, 2017-2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35271557" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36355596" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Tobacco Product Use Among Middle and High School Students - United States, 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36355596" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Tobacco Product Use Among Middle and High School Students - United States, 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29879097" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Tobacco Product Use Among Middle and High School Students - United States, 2011-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33048127" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Demographic Characteristics, Cigarette Smoking, and e-Cigarette Use Among US Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31688912" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : e-Cigarette Use Among Youth in the United States, 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30167658" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Prevalence and Distribution of E-Cigarette Use Among U.S. Adults: Behavioral Risk Factor Surveillance System, 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28624763" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Electronic cigarette use among US adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26525063" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Patterns of Electronic Cigarette Use Among Adults in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26525063" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Patterns of Electronic Cigarette Use Among Adults in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28710596" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Patterns of and reasons for electronic cigarette use in primary care patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27612572" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Reasons for current E-cigarette use among U.S. adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24951496" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Cigarette users' interest in using or switching to electronic nicotine delivery systems for smokeless tobacco for harm reduction, cessation, or novelty: a cross-sectional survey of US adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22311962" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Electronic cigarettes: effective nicotine delivery after acute administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29046158" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : E-cigarettes: Impact of E-Liquid Components and Device Characteristics on Nicotine Exposure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24049448" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23978909" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Acute electronic cigarette use: nicotine delivery and subjective effects in regular users.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28166548" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26430813" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24732160" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Electronic cigarettes and nicotine clinical pharmacology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22529223" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Nicotine levels in electronic cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24821826" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : E-cigarettes: a scientific review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24821826" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : E-cigarettes: a scientific review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24821826" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : E-cigarettes: a scientific review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31725707" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Evaluation of Bronchoalveolar Lavage Fluid from Patients in an Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - 10 States, August-October 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31751326" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Characteristics of Hospitalized and Nonhospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, November 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31971931" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Update: Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, August 2019-January 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32320569" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Hospitalizations and Deaths Associated with EVALI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32320569" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Hospitalizations and Deaths Associated with EVALI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24399548" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Promise and peril of e-cigarettes: can disruptive technology make cigarettes obsolete?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24832759" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22512236" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Mechanisms of propylene glycol and triacetin pyrolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25607446" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Hidden formaldehyde in e-cigarette aerosols.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25607446" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Hidden formaldehyde in e-cigarette aerosols.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28332500" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Cardiovascular effects of electronic cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28146259" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Increased Cardiac Sympathetic Activity and Oxidative Stress in Habitual Electronic Cigarette Users: Implications for Cardiovascular Risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28931527" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Sympathomimetic Effects of Acute E-Cigarette Use: Role of Nicotine and Non-Nicotine Constituents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31740017" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31740017" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26551991" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Electronic Cigarette Use and Respiratory Symptoms in Chinese Adolescents in Hong Kong.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27806211" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Electronic Cigarette Use and Respiratory Symptoms in Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31922902" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Electronic Cigarette Use and Chronic Respiratory Symptoms among U.S. Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30760629" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the Population Assessment of Tobacco and Health (PATH) study, wave 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25383564" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Flavorings in electronic cigarettes: an unrecognized respiratory health hazard?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25180080" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Evaluation of electronic cigarette liquids and aerosol for the presence of selected inhalation toxins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24516877" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Identification of toxicants in cinnamon-flavored electronic cigarette refill fluids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30808901" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Identification of Cytotoxic Flavor Chemicals in Top-Selling Electronic Cigarette Refill Fluids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24135821" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22989551" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26642857" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26822067" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Cherry-flavoured electronic cigarettes expose users to the inhalation irritant, benzaldehyde.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29435573" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Balancing the Benefits and Harms of E-Cigarettes: A National Academies of Science, Engineering, and Medicine Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27664185" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Burns from e-cigarettes and other electronic nicotine delivery systems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27705271" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Explosion Injuries from E-Cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Burns injuries from e-cigarettes kept in pockets</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33041151" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Electronic cigarette explosion/burn and poisoning related emergency department visits, 2018-2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28651887" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Alarming increase in electronic nicotine delivery systems-related burn injuries: A serious unregulated public health issue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26284721" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26348249" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Progression to Traditional Cigarette Smoking After Electronic Cigarette Use Among US Adolescents and Young Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27296866" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : E-Cigarettes and Future Cigarette Use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28654986" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28617772" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Electronic Cigarettes as an Introductory Tobacco Product Among Eighth and 11th Grade Tobacco Users - Oregon, 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32888234" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Gateway or common liability? A systematic review and meta-analysis of studies of adolescent e-cigarette use and future smoking initiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29131876" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Errors in Data Input in Meta-analysis on Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28115540" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : E-cigarettes and National Adolescent Cigarette Use: 2004-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22194587" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32798097" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26504128" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Electronic Nicotine Delivery Systems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26504128" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Electronic Nicotine Delivery Systems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26504133" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Public Policy to Protect Children From Tobacco, Nicotine, and Tobacco Smoke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27401100" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Potential Solutions to Electronic Cigarette Use Among Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24650842" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : "Smoking revolution": a content analysis of electronic cigarette retail websites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24439352" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Beliefs and experimentation with electronic cigarettes: a prospective analysis among young adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31659003" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : E-cigarette Marketing Exposure and Subsequent Experimentation Among Youth and Young Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27080732" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : E-Cigarette Marketing Exposure Is Associated With E-Cigarette Use Among US Youth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33464343" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34519354" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Electronic cigarettes for smoking cessation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24830741" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : E-cigarette versus nicotine inhaler: comparing the perceptions and experiences of inhaled nicotine devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32663106" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30699054" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33170225" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Randomized Trials of e-Cigarettes for Smoking Cessation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24029165" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Electronic cigarettes for smoking cessation: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23415116" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Electronic nicotine delivery systems: international tobacco control four-country survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21989407" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23873169" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23488521" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Alternative tobacco product use and smoking cessation: a national study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24664434" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : A longitudinal analysis of electronic cigarette use and smoking cessation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24846453" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26519457" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Smoking Cessation and Electronic Cigarette Use among Head and Neck Cancer Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26776875" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28747333" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31305860" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Association Between Electronic Cigarette Use and Smoking Reduction in France.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31298296" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Electronic Cigarette Use and Cigarette Abstinence Over 2 Years Among U.S. Smokers in the Population Assessment of Tobacco and Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25880947" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : E-cigarette use in the past and quitting behavior in the future: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25252116" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25209468" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : E-cigarettes--aid to smoking cessation or smokescreen?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25961965" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Electronic Cigarettes: Perhaps the Devil Unknown Is Better Than the Devil Known.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33857436" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33857436" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24979277" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : E-cigarettes, vaping, and youth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24633865" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : E-cigarettes and the future of tobacco control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24350902" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : The renormalization of smoking? E-cigarettes and the tobacco "endgame".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22913171" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Electronic cigarettes: an evaluation of exposure to chemicals and fine particulate matter (PM).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24406205" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22672560" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Does e-cigarette consumption cause passive vaping?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24958250" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24958250" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25006874" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Electronic cigarettes. A position statement of the forum of international respiratory societies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25572671" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25894027" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Electronic nicotine delivery systems: executive summary of a policy position paper from the American College of Physicians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26267620" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Differential Taxes for Differential Risks--Toward Reduced Harm from Nicotine-Yielding Products.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25193956" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Regulation of electronic cigarettes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25192694" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : WHO review exaggerated dangers of e-cigarettes, say specialists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25192694" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : WHO review exaggerated dangers of e-cigarettes, say specialists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid164" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>165 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid165" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>166 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27122374" id="rid166" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>167 : Nicotine without smoke-putting electronic cigarettes in context.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25156991" id="rid167" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>168 : Electronic cigarettes: a policy statement from the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26002957" id="rid168" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>169 : Electronic Cigarettes: A Primer for Clinicians.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
